MAM
HALO icon

Myriad Asset Management’s Halozyme HALO Stock Holding History

Myriad Asset Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$3.07M Hold
77,000
– – 0.43% 28
2021
Q4 		$3.1M Buy
77,000
+16,500
+27% +$616K 0.34% 52
2021
Q3 		$2.46M Buy
+60,500
New +$2.53M 0.25% 73

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.79B AUM 33.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Myriad Asset Management's HALO Position: Q1 2022 in Review

Myriad Asset Management held its Halozyme (HALO) position steady in Q1 2022 at 77,000 shares worth $3.07M. The position accounts for 0.43% of the portfolio, ranked #28.

Myriad Asset Management first reported a position in HALO in Q3 2021 and has held it in 3 quarters since. The position peaked at $3.1M in Q4 2021. 318 funds tracked by Wall St. Rank hold HALO as of Q1 2022.

  • Myriad Asset Management held 77,000 shares of Halozyme worth $3.07M as of Q1 2022.
  • Myriad Asset Management left its Halozyme share count unchanged in Q1 2022.
  • Halozyme made up 0.43% of Myriad Asset Management's portfolio in Q1 2022, its #28 holding.
  • Myriad Asset Management first reported a position in Halozyme in Q3 2021 and has held it in 3 quarters since.
  • Myriad Asset Management's Halozyme position peaked at $3.1M in Q4 2021.
  • 318 funds tracked by Wall St. Rank held Halozyme as of Q1 2022.

Based on Myriad Asset Management's 13F filing for Q1 2022, filed 16 May 2022.